Evidence map›Paper›PMID 41867364›Full record

ArticleMolecular vision2025

Analysis of cytogenetic germline changes in Polish patients with retinoblastoma.

Dorota Wicher, Danuta Sielska-Rotblum, Urszula Zawadzka-Wiech, Monika Kowalczyk-Rusak, Olga Rutynowska-Pronicka, Agnieszka Gietka, Elwira Kulicka, Marlena Mlynek

Abstract read
In one paragraph

Article in Molecular vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dorota WicherDepartment of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.
Danuta Sielska-RotblumDepartment of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.
Urszula Zawadzka-WiechDepartment of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.
Monika Kowalczyk-RusakDepartment of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.
Olga Rutynowska-PronickaDepartment of Oncology, Children's Memorial Health Institute, Warsaw, Poland.
Agnieszka GietkaDepartment of Oncology, Children's Memorial Health Institute, Warsaw, Poland.
Elwira KulickaDepartment of Oncology, Children's Memorial Health Institute, Warsaw, Poland.
Marlena MlynekDepartment of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Retinoblastoma, the most common eye tumor in children, can occur in hereditary or nonhereditary forms. In the hereditary form, various germline alterations, single nucleotide (SNVs) or copy number variations (CNVs) in the Methods: The results of genetic testing for germline mutations in patients with retinoblastoma performed between 2013 and 2023 were analyzed. In patients with cytogenetic alterations (CNV group, n = 19), the form of disease, age of onset, the first symptom, family history, and the type and extent of cytogenetic changes were verified. Comparative analyses were conducted between the CNV and SNV (n = 83) groups as well as the group of patients with normal genetic test results (n = 126). Results: Cytogenetic changes were detected in 19 probands. These included: 16 deletions (10 partial and 6 whole gene deletions), 2 duplications, and 1 balanced translocation. Partial gene deletions included from 1 to 16 exons. In the CNV group, bilateral involvement predominated, with strabismus being the most common initial symptom. The mean age of onset was 16.9 months (median = 11 months; IQR, 8-22 months) and was lower in patients with bilateral involvement and partial gene deletions. Statistically significant differences compared to patients with normal genetic test results were observed in terms of laterality, the age of onset, initial symptom, and the family history of retinoblastoma. No such differences were found between the CNV and SNV groups. Conclusions: Cytogenetic changes constitute a significant part of germline alterations in patients with retinoblastoma. Cytogenetic techniques should still be considered in diagnostic protocols, especially in patients with bilateral involvement and/or positive family history, as well as in parents of patients with CNV.

Indexed as

Germ-Line MutationRetinal NeoplasmsRetinoblastomaRetinoblastoma ProteinUbiquitin-Protein LigasesAge of OnsetChildChild, PreschoolCytogenetic AnalysisDNA Copy Number VariationsFemaleGene DeletionHigh-Throughput Nucleotide SequencingHumansInfantMaleRB1 protein, humanRetinoblastoma Binding ProteinsRetinoblastoma ProteinUbiquitin-Protein Ligases

Identifiers

PMID41867364
PMCPMC13002341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.